Chapter 15 Ruling Sets Restructuring Blueprint for Cannabis Companies

Cross-Border Restructuring Access Opens for Cannabis Debtors

The Chapter 15 recognition allows cannabis companies incorporated in jurisdictions where cannabis is legal to access U.S. bankruptcy protections through foreign proceedings, circumventing the federal illegality bar that's blocked domestic Chapter 11 filings. The ruling came from a U.S. Bankruptcy Court evaluating a Canadian Licensed Producer's restructuring under Canada's Companies' Creditors Arrangement Act (CCAA).

Chapter 15 of the U.S. Bankruptcy Code governs recognition of foreign insolvency proceedings. Courts must recognize proceedings from a debtor's "center of main interests" (COMI) and extend cooperation to foreign tribunals. Cannabis companies have been shut out of U.S. bankruptcy courts since the Controlled Substances Act classifies cannabis as a Schedule I narcotic. Any reorganization plan becomes, in effect, a plan to continue federal crimes.

This decision turns on COMI. The debtor's operations, management, and regulatory licenses were all in Canada, where adult-use cannabis has been federally legal since 2018. U.S. public policy concerns—the traditional brake on Chapter 15 recognition—didn't override comity when the debtor's entire business was lawful in its home jurisdiction and had no U.S. cultivation or distribution footprint, the court found.

Implications for U.S. Multi-State Operators

The ruling creates a restructuring arbitrage: MSOs with Canadian parent entities or substantial Canadian operations may now engineer COMI shifts to access bankruptcy protections unavailable to purely domestic operators. Legal experts quoted in the Law360 report noted the decision will likely prompt cannabis companies to evaluate corporate domicile and operational center-of-gravity as restructuring variables.

The math is compelling for distressed operators. Chapter 15 recognition brings automatic stay protections, creditor coordination mechanisms, and court supervision. All absent from out-of-court workouts that have been the only option for U.S. cannabis debtors.

But the pathway isn't frictionless. A debtor must demonstrate its COMI is genuinely foreign, not a litigation convenience. Courts apply a multi-factor test weighing location of headquarters, management, primary assets, and the jurisdiction whose law would apply to most disputes. An MSO with token Canadian operations and 90% of revenue from U.S. dispensaries would fail that test.

Distressed-Debt Market Watches for Replication

Bankruptcy practitioners are now monitoring whether other circuits will follow the decision or whether appellate review will narrow its application. The ruling isn't binding outside its district. Cannabis bankruptcy law remains a judicial patchwork. One Delaware bankruptcy judge dismissed a cannabis case in 2020 on public-policy grounds; another in Colorado allowed a hemp-derived CBD company to proceed after reclassification under the 2018 Farm Bill.

Timing matters here. Cannabis distress is acute. Wholesale prices in mature markets like California and Colorado have fallen 40-60% since 2021, compressing margins for cultivators and manufacturers. High-leverage MSOs face refinancing walls in 2026 and 2027, and the lack of bankruptcy protection has pushed several operators into receivership or distressed M&A at steep discounts.

For a deeper look at cannabis insolvency trends and restructuring mechanics, see the CannIntel topic hub on cannabis bankruptcy and restructuring. The next signal: whether a U.S. MSO attempts a COMI shift to Ontario or British Columbia to test the ruling's boundaries. Distressed-debt funds with cross-border structuring experience are already modeling the playbook.